Thrombogenix enters preclinical development

被引：0
|
作者：
不详
机构：
来源：
AUSTRALASIAN BIOTECHNOLOGY | 1999年 / 9卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [31] CHANGE CHARACTERIZES RESEARCH-AND-DEVELOPMENT AS INDUSTRY ENTERS 1986
    JONES, RR
    RESEARCH & DEVELOPMENT, 1986, 28 (03): : 73 - 76
  • [32] Nuclear Power Industry of China Enters a New Stage of Development
    By Qi Enlan China Power Engineering Consulting Group Co.
    Electricity, 2005, (04) : 11 - 14
  • [33] Hindustan Aeronautics enters advanced development phase, says source
    Jane's Def. Ind., 2006, DEC.
  • [34] Impossible Objects enters joint development agreement with Owens Corning
    不详
    GLASS TECHNOLOGY-EUROPEAN JOURNAL OF GLASS SCIENCE AND TECHNOLOGY PART A, 2021, 62 (02): : 64 - 64
  • [35] On the Clock: Gulf of Mexico Enters the Offshore Wind Development Race
    Presley, Jennifer
    JPT, Journal of Petroleum Technology, 2022, 74 (09): : 29 - 33
  • [36] Preclinical development of neuropeptide therapeutics and diagnostics
    Steinmetz, Karen L.
    NEUROPEPTIDES, 2008, 42 (01) : 114 - 114
  • [37] PHARMACOTHERAPY OF COCAINE ABUSE - PRECLINICAL DEVELOPMENT
    WITKIN, JM
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1994, 18 (01): : 121 - 142
  • [38] Preclinical development and characterization of MYC inhibitors
    Jacob, Nicholas
    Miranda, Pedro
    Navarro, Pedro Serrano
    Hart, Jonathan
    Vogt, Peter
    Janda, Kim
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [39] Corallopyronin A: antimicrobial discovery to preclinical development
    Krome, Anna K.
    Becker, Tim
    Kehraus, Stefan
    Schiefer, Andrea
    Gutschow, Michael
    Chaverra-Munoz, Lillibeth
    Huttel, Stephan
    Jansen, Rolf
    Stadler, Marc
    Ehrens, Alexandra
    Pogorevc, Domen
    Muller, Rolf
    Hubner, Marc P.
    Hesterkamp, Thomas
    Pfarr, Kenneth
    Hoerauf, Achim
    Wagner, Karl G.
    Konig, Gabriele M.
    NATURAL PRODUCT REPORTS, 2022, 39 (09) : 1705 - 1720
  • [40] Modelling in preclinical and clinical drug development
    Balant, LP
    Gex-Fabry, M
    PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH: BIOLOGICAL, PHYSICOCHEMICAL, AND COMPUTATIONAL STRATEGIES, 2001, : 15 - 29
12345